Gilead Sciences Inc. is a biopharmaceutical company that’s pursued and achieved breakthroughs in medicine for more than three decades, with a goal of creating a healthier future for all people.

Gilead has approved products for both haematological malignancies and solid tumours and an extensive clinical development programme covering many cancer types.